Lakefront Biotherapeutics - American Depositary Shares (NQ:LKFT)

34.09 UNCHANGED

Delayed Quote Updated: 4:00 PM EST, Nov 4, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Lakefront Biotherapeutics - American Depositary Shares

Lakefront Biotherapeutics Targets 2027 Registrational Trials for Gamgertamig ↗

September 21, 2026

Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) said it plans to begin registrational studies next year for its lead T-cell engager, gamgertamig, following a broad restructuring of...

Via MarketBeat

Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline

June 04, 2026

From Gilead Sciences, Inc.

Via Business Wire

What to Know About This Fund's $10 Million Nektar Bet Ahead of a Key Phase 3 Launch ↗

May 23, 2026

Biotech firm Nektar Therapeutics advances a pipeline of immunology and oncology candidates through research-driven collaborations.

Via The Motley Fool

This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34% ↗

May 23, 2026

GeneDx Holdings delivers AI-powered clinical and genomic data analysis for healthcare providers seeking precision medicine solutions.

Via The Motley Fool

Topics Artificial Intelligence

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.